(2021), patients with T2DM, those with acute COVID-19, and those who recovered from COVID-19 all were found to yield greater insulin and C-peptide secretion following arginine administration, consistent with acute and long-term β-cell hypersecretion and IR following COVID-19 (98, 101). Here, INS is linked to COVID-19.